Scorpius Holdings Files 8-K on Financials & Operations

TL;DR

SCPX filed an 8-K on May 29th detailing financials and operations. Formerly NightHawk Biosciences.

AI Summary

Scorpius Holdings, Inc. filed an 8-K on May 29, 2024, reporting on its results of operations and financial condition. The filing also covers shareholder nominations and other events, including financial statements and exhibits. The company was formerly known as NightHawk Biosciences, Inc. and HEAT BIOLOGICS, INC.

Why It Matters

This 8-K filing provides crucial updates on Scorpius Holdings' financial performance and operational status, which are key indicators for investors assessing the company's health and future prospects.

Risk Assessment

Risk Level: medium — 8-K filings can contain significant information, but without specific financial details or forward-looking statements in this summary, the risk level is moderate.

Key Players & Entities

• Scorpius Holdings, Inc. (company) — Registrant
• May 29, 2024 (date) — Filing Date
• NightHawk Biosciences, Inc. (company) — Former Company Name
• HEAT BIOLOGICS, INC. (company) — Former Company Name
• Delaware (jurisdiction) — State of Incorporation

FAQ

Key Financial Figures

• $0.0002 — nge on which registered Common Stock, $0.0002 par value per share SCPX NYSE Ameri

Filing Documents

• scpx-20240529x8k.htm (8-K) — 43KB
• scpx-20240529xex99d1.htm (EX-99.1) — 13KB
• scpx-20240529xex99d1001.jpg (GRAPHIC) — 12KB
• 0001558370-24-008704.txt ( ) — 259KB
• scpx-20240529.xsd (EX-101.SCH) — 4KB
• scpx-20240529_def.xml (EX-101.DEF) — 14KB
• scpx-20240529_lab.xml (EX-101.LAB) — 16KB
• scpx-20240529_pre.xml (EX-101.PRE) — 14KB
• scpx-20240529x8k_htm.xml (XML) — 7KB

02 Results of Operations and Financial Condition

Item 2.02 Results of Operations and Financial Condition. On May 29, 2024, Scorpius Holdings, Inc., a Delaware corporation (the "Company"), issued the attached press release that included financial information for its quarter ended March 31, 2024. A copy of the press release is attached as Exhibit 99.1 to this Current Report on Form 8-K. The information in this Item 2.02 and in the press release attached as Exhibit 99.1 to this Current Report on Form 8-K shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended. The information contained in this Item 2.02 and in the press release attached as Exhibit 99.1 to this Current Report on Form 8-K shall not be incorporated by reference into any filing with the U.S. Securities and Exchange Commission made by the Company, whether made before or after the date hereof, regardless of any general incorporation language in such filing.

08. Shareholder Director Nominations

Item 5.08. Shareholder Director Nominations. To the extent applicable, the information in Item 8.01 of this Current Report on Form 8-K is incorporated by reference into this Item 5.08.

01. Other Events

Item 8.01. Other Events. The Company currently plans to hold its 2024 Annual Meeting of Stockholders (the "2024 Annual Meeting") on August 2, 2024. The Company record date for determining the stockholders of record who will be entitled to vote at the 2024 Annual Meeting will be close of business on June 13, 2024. The time and location of the 2024 Annual Meeting will be as set forth in the Company's definitive proxy statement for the 2024 Annual Meeting to be filed with the Securities and Exchange Commission. Because the scheduled date of the 2024 Annual Meeting is more than 30 days prior to the anniversary of the Company's 2023 Annual Meeting of Stockholders, prior disclosed deadlines regarding the submission of stockholder proposals pursuant to Rule 14a-8 ("Rule 14a-8") under the Securities Exchange Act of 1934, as amended (the "Exchange Act"), for the 2024 Annual Meeting are no longer applicable. The Company is hereby providing notice of certain revised deadlines for the submission of stockholder proposals in connection with the 2024 Annual Meeting. In order for a stockholder proposal, submitted pursuant to Rule 14a-8, to be considered timely for inclusion in the Company's proxy statement and form of proxy for the 2024 Annual Meeting, such proposal must be received by the Company by June 8, 2024. The Company has determined that June 8, 2024 is a reasonable time before the Company plans to begin printing and mailing its proxy materials. Therefore, in order for a stockholder to submit a proposal for inclusion in the Company's proxy materials for the 2024 Annual Meeting, the stockholder must comply with the requirements set forth in Rule 14a-8, including with respect to the subject matter of the proposal, and must deliver the proposal and all required documentation to the Company no later than June 8, 2024. The public announcement of an adjournment or postponement of the date of the 2024 Annual Meeting will not commence a new time period (or extend any time period

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 99.1 Press Release issued by Scorpius Holdings, Inc. May 29, 2024 104 Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: May 29, 2024 SCORPIUS HOLDINGS, INC. By: /s/ Jeffrey Wolf Name: Jeffrey Wolf Title: Chairman, President and Chief Executive Officer

View Full Filing

View this 8-K filing on SEC EDGAR